Benzinga | May 6, 2021 05:14PM EDT

Lexicon Pharmaceuticals Q1 EPS $(0.15) Beats $(0.16) Estimate, Sales $27.00K Miss $1.68M Estimate

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.16) by 6.25 percent. This is a 76.19 percent increase over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $27.00 thousand which missed the analyst consensus estimate of $1.68 million by 98.39 percent. This is a 99.66 percent decrease over sales of $8.00 million the same period last year.